EUVIMEDEUVIMED entdecken
Open Access

Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making

Richard T Kloos

Molecular Imaging and Radionuclide Therapy · 01.02.2017 · 26 (1(1)) · 36-49

DOI: 10.4274/2017.26.suppl.05 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Imaging and Radionuclide Therapy, erschienen am 01.02.2017. Verfasst von Richard T Kloos. Beteiligte Einrichtung: Veracyte, Inc., Department of Medical Affairs, Senior Medical Director-Endocrinology, California, USA, Phone: +1(650)243-6300, E-mail: richard.kloos@…. Die Arbeit wurde bisher 43-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Veracyte, Inc., Department of Medical Affairs, Senior Medical Director-Endocrinology, California, USA, Phone: +1(650)243-6300, E-mail: richard.kloos@veracyte.com.

Zitieren

APA

Kloos, R. T. (2017). Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making. Molecular Imaging and Radionuclide Therapy, 26(1(1)), 36-49. https://doi.org/10.4274/2017.26.suppl.05

Vancouver

Kloos RT. Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making. Molecular Imaging and Radionuclide Therapy. 2017;26(1(1)):36-49. doi:10.4274/2017.26.suppl.05

BibTeX
@article{Kloos2017,
  author = {Kloos, Richard T},
  title = {Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making},
  journal = {Molecular Imaging and Radionuclide Therapy},
  year = {2017},
  volume = {26},
  number = {1(1)},
  pages = {36--49},
  doi = {10.4274/2017.26.suppl.05}
}
Kostenlos starten →